Rejuvenate Biomed is a Belgian based biomedical company engaged in developing prescription drugs in healthy ageing. By applying the progress made in geroscience (biology of aging) we identify and develop (up to POC) safe and well tolerated drugs that balance core biological processes associated with age-related functional decline.
1
Funding Rounds
$15.7m
Money raised
Access comprehensive data and insights available only to Seedtable members
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
The company Rejuvenate Biomed has raised a total of $15.7m in funding over 1 rounds.